Annual EBIT
-$29.63 M
+$1.01 M+3.29%
31 December 2023
Summary:
Moleculin Biotech annual earnings before interest & taxes is currently -$29.63 million, with the most recent change of +$1.01 million (+3.29%) on 31 December 2023. During the last 3 years, it has fallen by -$9.89 million (-50.09%). MBRX annual EBIT is now -663.10% below its all-time high of -$3.88 million.MBRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$7.13 M
-$950.00 K-15.36%
30 September 2024
Summary:
Moleculin Biotech quarterly earnings before interest & taxes is currently -$7.13 million, with the most recent change of -$950.00 thousand (-15.36%) on 30 September 2024. Over the past year, it has dropped by -$1.19 million (-19.98%). MBRX quarterly EBIT is now -2122.74% below its all-time high of -$321.00 thousand, reached on 31 March 2016.MBRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$28.92 M
-$1.19 M-4.28%
30 September 2024
Summary:
Moleculin Biotech TTM earnings before interest & taxes is currently -$28.92 million, with the most recent change of -$1.19 million (-4.28%) on 30 September 2024. Over the past year, it has dropped by -$1.16 million (-4.16%). MBRX TTM EBIT is now -8908.10% below its all-time high of -$321.00 thousand, reached on 31 March 2016.MBRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MBRX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.3% | -20.0% | -4.2% |
| 3 y3 years | -50.1% | -15.9% | -36.0% |
| 5 y5 years | -97.2% | -58.3% | -69.6% |
MBRX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -50.1% | +3.3% | -37.1% | +21.5% | -36.0% | +9.4% |
| 5 y | 5 years | -97.2% | +3.3% | -104.2% | +21.5% | -69.6% | +9.4% |
| alltime | all time | -663.1% | +3.3% | -2122.7% | +21.5% | -8908.1% | +9.4% |
Moleculin Biotech EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.13 M(+15.4%) | -$28.92 M(+4.3%) |
| June 2024 | - | -$6.18 M(-7.4%) | -$27.73 M(-0.8%) |
| Mar 2024 | - | -$6.68 M(-25.1%) | -$27.95 M(-5.7%) |
| Dec 2023 | -$29.63 M(-3.3%) | -$8.92 M(+50.0%) | -$29.63 M(+6.7%) |
| Sept 2023 | - | -$5.95 M(-7.2%) | -$27.76 M(-10.2%) |
| June 2023 | - | -$6.41 M(-23.3%) | -$30.90 M(-3.2%) |
| Mar 2023 | - | -$8.35 M(+18.5%) | -$31.92 M(+4.2%) |
| Dec 2022 | -$30.64 M(+33.4%) | -$7.05 M(-22.4%) | -$30.64 M(+6.4%) |
| Sept 2022 | - | -$9.08 M(+22.2%) | -$28.80 M(+11.3%) |
| June 2022 | - | -$7.43 M(+5.1%) | -$25.87 M(+8.0%) |
| Mar 2022 | - | -$7.07 M(+35.9%) | -$23.95 M(+4.3%) |
| Dec 2021 | -$22.97 M(+16.3%) | -$5.21 M(-15.5%) | -$22.97 M(+8.0%) |
| Sept 2021 | - | -$6.16 M(+11.6%) | -$21.26 M(+0.0%) |
| June 2021 | - | -$5.52 M(-9.4%) | -$21.25 M(+2.3%) |
| Mar 2021 | - | -$6.09 M(+74.2%) | -$20.77 M(+5.2%) |
| Dec 2020 | -$19.74 M | -$3.50 M(-43.2%) | -$19.74 M(-6.3%) |
| Sept 2020 | - | -$6.15 M(+22.2%) | -$21.06 M(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$5.03 M(-0.6%) | -$19.42 M(+7.8%) |
| Mar 2020 | - | -$5.06 M(+5.2%) | -$18.02 M(+2.8%) |
| Dec 2019 | -$17.52 M(+16.6%) | -$4.81 M(+6.8%) | -$17.52 M(+2.8%) |
| Sept 2019 | - | -$4.51 M(+24.1%) | -$17.05 M(+12.7%) |
| June 2019 | - | -$3.63 M(-20.5%) | -$15.13 M(-10.8%) |
| Mar 2019 | - | -$4.57 M(+5.4%) | -$16.96 M(+12.9%) |
| Dec 2018 | -$15.03 M(+73.6%) | -$4.34 M(+67.4%) | -$15.02 M(+6.7%) |
| Sept 2018 | - | -$2.59 M(-52.5%) | -$14.08 M(+1.3%) |
| June 2018 | - | -$5.46 M(+107.0%) | -$13.89 M(+42.4%) |
| Mar 2018 | - | -$2.64 M(-22.3%) | -$9.75 M(+31.0%) |
| Dec 2017 | -$8.65 M(+122.8%) | -$3.39 M(+41.1%) | -$7.45 M(+36.1%) |
| Sept 2017 | - | -$2.40 M(+82.1%) | -$5.47 M(+21.9%) |
| June 2017 | - | -$1.32 M(+302.4%) | -$4.49 M(+15.3%) |
| Mar 2017 | - | -$328.00 K(-76.9%) | -$3.89 M(+0.2%) |
| Dec 2016 | -$3.88 M | -$1.42 M(-0.4%) | -$3.88 M(+57.4%) |
| Sept 2016 | - | -$1.42 M(+96.4%) | -$2.47 M(+136.1%) |
| June 2016 | - | -$724.00 K(+125.5%) | -$1.04 M(+225.5%) |
| Mar 2016 | - | -$321.00 K | -$321.00 K |
FAQ
- What is Moleculin Biotech annual earnings before interest & taxes?
- What is the all time high annual EBIT for Moleculin Biotech?
- What is Moleculin Biotech annual EBIT year-on-year change?
- What is Moleculin Biotech quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Moleculin Biotech?
- What is Moleculin Biotech quarterly EBIT year-on-year change?
- What is Moleculin Biotech TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Moleculin Biotech?
- What is Moleculin Biotech TTM EBIT year-on-year change?
What is Moleculin Biotech annual earnings before interest & taxes?
The current annual EBIT of MBRX is -$29.63 M
What is the all time high annual EBIT for Moleculin Biotech?
Moleculin Biotech all-time high annual earnings before interest & taxes is -$3.88 M
What is Moleculin Biotech annual EBIT year-on-year change?
Over the past year, MBRX annual earnings before interest & taxes has changed by +$1.01 M (+3.29%)
What is Moleculin Biotech quarterly earnings before interest & taxes?
The current quarterly EBIT of MBRX is -$7.13 M
What is the all time high quarterly EBIT for Moleculin Biotech?
Moleculin Biotech all-time high quarterly earnings before interest & taxes is -$321.00 K
What is Moleculin Biotech quarterly EBIT year-on-year change?
Over the past year, MBRX quarterly earnings before interest & taxes has changed by -$1.19 M (-19.98%)
What is Moleculin Biotech TTM earnings before interest & taxes?
The current TTM EBIT of MBRX is -$28.92 M
What is the all time high TTM EBIT for Moleculin Biotech?
Moleculin Biotech all-time high TTM earnings before interest & taxes is -$321.00 K
What is Moleculin Biotech TTM EBIT year-on-year change?
Over the past year, MBRX TTM earnings before interest & taxes has changed by -$1.16 M (-4.16%)